Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
For the treatment of many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.
Joint Reconstruction Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Presbyterian Church East Africa Kikuyu Hospital, Kikuyu, Kenya
Pfizer Investigational Site, Shanghai, China
Department of Surgery, University hospital Sahlgrenska/Östra, Gothenburg, Sweden
Department of Surgery and oncology, Halland Hospital in Halmstad, Halmstad, Sweden
Department of surgery, Community Hospital i Karlskrona, Karlskrona, Sweden
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Hôpitaux Universitaire de Genève, Geneva, Switzerland
Hospital Clínic, Barcelona, Catalonia, Spain
Ninewells Hospital and Medical School, Dundee, Angus, United Kingdom
Hvidovre University Hospital, Hvidovre, Denmark
University Hospital Antwerp, UZA Ophthalmology, Antwerp, Belgium
Ospedale Borgo Trento, Verona, Italy
Jan Yperman Ziekenhuis, Ieper, Belgium
Univ of California / San Diego Treatment Ctr, San Diego, California, United States
Thomas Jefferson Univ Hosp, Philadelphia, Pennsylvania, United States
Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco, California, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.